Ecoscience (ECSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ecoscience (ECSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WWS who wrote (10)	8/14/1996 10:09:00 AM
From: Steve Harmon	of 145

4th qtr. numbers probably will not be great. Revenue should be around $3.5- 4 mil. That gives them $15-16 mil. for the year.Profits should begin in the 1st or 2nd Qtr. this fiscal year which began in June. If not by then Fiscal 97(this fiscal year in total will be profitable). The degree of profits will be determined by marketing partner deals to be completed for Bio-Path and Bio-Save. These marketing deals or news on the Terminix front should spark the stock to higher levels. Remember recent restructuring deals valued the stock at the $4-5 range.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next